112 related articles for article (PubMed ID: 27993216)
1. Vascular endothelial growth factor expression is an independent poor prognostic factor for human epidermal growth factor receptor 2 positive gastric cancer.
Hsu JT; Chen TD; Chuang HC; Huang SC; Le PH; Chen TH; Lin CJ; Yeh TS
J Surg Res; 2017 Feb; 208():40-50. PubMed ID: 27993216
[TBL] [Abstract][Full Text] [Related]
2. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
4. Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.
Hsu JT; Chen TC; Tseng JH; Chiu CT; Liu KH; Yeh CN; Hwang TL; Jan YY; Yeh TS
Oncologist; 2011; 16(12):1706-13. PubMed ID: 22143936
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of nuclear factor-κB and vascular endothelial growth factor expression in advanced gastric cancer patients.
Park KW; Kim SJ; Oh SY
Oncol Res Treat; 2014; 37(4):183-90. PubMed ID: 24732642
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
Yang X; Sun HJ; Li ZR; Zhang H; Yang WJ; Ni B; Wu YZ
BMC Cancer; 2015 Feb; 15():80. PubMed ID: 25886574
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer.
Geng Y; Chen X; Qiu J; Zhou Y; Wang J; Liu L; Shao Y; Yin Y
Int J Clin Oncol; 2014 Apr; 19(2):303-11. PubMed ID: 23660785
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
12. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Konecny GE; Meng YG; Untch M; Wang HJ; Bauerfeind I; Epstein M; Stieber P; Vernes JM; Gutierrez J; Hong K; Beryt M; Hepp H; Slamon DJ; Pegram MD
Clin Cancer Res; 2004 Mar; 10(5):1706-16. PubMed ID: 15014023
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
[TBL] [Abstract][Full Text] [Related]
15. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
Liu W; Zhong S; Chen J; Yu Y
J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
19. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
20. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
